Preclinical Study Suggests New Therapy Could Wipe Out Brain

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
46
Preclinical Study Suggests New Therapy Could Wipe Out Brain Tumors


UC San Francisco-based scientists have developed a new immunotherapy that was successful in wiping out all tumor cells inside the brains of the mice that were treated with this intervention. The success of this preclinical study has encouraged the researchers to expedite their plans to test the treatment in human subjects.

The study, which was led by Senthilnath Lakshmanachetty, focused on a deadly pediatric cancer called DMG, or diffuse midline glioma. This cancer is so aggressive that most patients die within a year after being diagnosed, and current treatments have had limited success in controlling this malignancy.

The UCSF scientists wanted to find a way to make immunotherapy helpful to patients diagnosed with this disease. The team noted that the CAR-T cells used in existing immunotherapies only worked for a short time and then the cancer would resume its progression.

The scientists wanted to find out whether engineering CAR-T cells so that they only get activated once they reach the brain could make the therapy more effective against DMG. They identified a protein that is only present inside the brain and they engineered CAR-T cells that can only trigger an anticancer response once they detect the presence of the brain-specific protein.

This meant that the immunotherapy could only become active once it entered the brain. When they infused these B-SYNC cells into mice having human DMG, the scientists were pleasantly surprised to find that the therapy eliminated all the tumors in the brains of the mice. They reintroduced DMG cells into the treated mice nearly two months after the initial treatment and the administered B-SYNC cells were still able to fight off the new tumor cells.

The data shows that the treatment remains active inside the brain long after initial administration. Actually, tests conducted 70 days after the initial treatment indicated that the B-SYNC cells were still actively on guard against tumor cells.

The researchers suggest that the success of their engineered immune cells could be because the cells remain inactive until they get inside the brain, giving them an opportunity to wage a spirited fight against tumors for a lot longer. They point to T-cell exhaustion as a reason why existing immunotherapies have a limited window of activity after which cancer progression resumes once the CAR-T cells are exhausted.

Their approach allows the engineered immune cells to only become active once inside the brain, thereby allowing the cells to pack a heavy punch that ends up eliminating the tumors completely and provides protective benefits long after the treatment was administered.

The team was so encouraged by their findings that they are working to start human trials soon, with April 2027 as a possible start date for clinical trials. The fight against cancer is an all-hands-on-deck undertaking, so other companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) engaged in R&D programs geared at developing new treatments for brain cancer will be wishing the UCSF team well as they move B-SYNC to the next levels of testing.

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

CNS Pharmaceuticals Inc. (CNSP) Stock Research Links

CNSP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SKINformed Bets on Skin Longevity Over Quick Fixes

Updated Category News Views 59

Wrinkle panic has been a very profitable racket for a long time, and SKINformed is trying to sidestep it. The physician-founded skincare brand is planting its flag on “SKINgevity,” a term it uses to describe long-term skin health rather than a frantic hunt for an overnight rewind. That is a sensible read on where beauty consumers appear to be headed: less appetite for...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 80

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Visa CEDP Data Gaps Are Quietly Hammering Merchants

Updated Category News Views 89

Somewhere between a checkout button and settlement, an awful lot of money is apparently falling through a trapdoor. Verisave and Canyon Payments say 93% of the 180 merchant accounts they reviewed during one month missed Visa Commercial Enhanced Data Program discounts they could have received. The claimed savings left on the table topped $800,000 for that group in that...

Continue Reading
Fayetteville Auction Puts Two Retail Sites Into Play

Updated Category News Views 77

Two lots staring across Sycamore Dairy Road are about to get a public price tag, and that is usually where the real estate story stops being polite. Iron Horse Auction Co. plans to sell a commercial showroom at 3618 Sycamore Dairy Road and a former batting cage facility at 3701 Sycamore Dairy Road through an online-only auction closing Dec. 9 beginning at 2 p.m. They sit...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 104

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 117

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading
Carnival Maps a Longer, Broader Bet on Cruise Demand

Updated Category News Views 16

A cruise operator does not order ships for 2035 because it is feeling timid. Carnival is laying out a long runway of hardware, private-destination capacity and onboard-to-onshore spending hooks, all aimed at keeping guests inside its ecosystem longer. For NYSE:CCL, this is not a next-quarter story. It is a very public statement that management sees enduring appetite for...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 31

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Dar Global’s $700M Qatar Bet Leans on Trump Branding

Updated Category News Views 29

Luxury property launches rarely arrive quietly, and this one came wrapped in Palm Beach ceremony, championship golf and a very loud brand name. Dar Global has formally introduced Trump International Simaisma, Qatar, a QAR 2.5 billion development—about $700 million—alongside The Trump Organization. That is a meaningful chunk of real estate ambition, not a little side...

Continue Reading

Top 5 Most Recently Viewed Articles

Join SeaStar Medical's CEO for Exciting Insights on Benzinga

Updated Category News Views 157

Join the CEO of SeaStar Medical on Benzinga All Access SeaStar Medical Holding Corporation (Nasdaq: ICU), recognized for its innovative approach in the healthcare sector, is proud to announce an exciting event featuring its CEO, Eric Schlorff. The event, scheduled for today, promises to be a significant moment for those interested in advancements in treatments for...

Continue Reading
E-Commerce Fuels Surge in Europe's Logistics Market Growth

Updated Category News Views 220

Surge in Europe's Logistics Market Driven by E-Commerce The logistics market in Europe is poised for remarkable growth, projected to expand by approximately USD 48.4 billion between 2025 and 2029. This growth trajectory, which reflects a compound annual growth rate (CAGR) of 3.4%, is predominantly fueled by the booming e-commerce sector. As consumer behaviors shift to...

Continue Reading
Procept Bio's 18% Dive: Unpacking Fraud Allegations

Updated Category News Views 64

Procept's Plunge: Not Your Average Market Tumble When a stock takes an 18% nosedive, it’s like ringing alarm bells down Wall Street. That’s exactly what happened with Procept BioRobotics Corporation (NASDAQ:PRCT), when it found itself knee-deep in controversies over alleged shady financial practices. The Allegations: Inflated Sales and Bulk Orders Procept allegedly...

Continue Reading
Key Outcomes from AB Akola Group's Latest Shareholder Meeting

Updated Category News Views 219

AB Akola Group's Extraordinary General Meeting Insights The Extraordinary General Meeting of AB Akola Group brought together shareholders to discuss various important agendas concerning the company's future. With a total shareholding of 167,170,481 shares, of which 166,566,819 held voting rights, the company witnessed an engaging assembly of its stakeholders. Major...

Continue Reading
GO Residential REIT Secures New Financing for Growth and Flexibility

Updated Category News Views 230

Enhancing Financial Stability: GO Residential REIT's New Financing GO Residential Real Estate Investment Trust (REIT) is thrilled to announce the successful refinancing of its prestigious property, One East River Place. This strategic move is designed to unlock significant liquidity and enhance the REIT's financial flexibility. The refinancing involves a new five-year...

Continue Reading